Predictors of overall survival following extended radical resections for locally advanced and recurrent pelvic malignancies.

Langenbeck's Archives of Surgery
Joseph C KongJacob McCormick

Abstract

In an era of personalised medicine, there is an overwhelming effort for predicting patients who will benefit from extended radical resections for locally advanced pelvic malignancy. However, there is paucity of data on the effect of comorbidities and postoperative complications on long-term overall survival (OS). The aim of this study was to define predictors of 1-year and 5-year OS. Data were collected from prospective databases at two high-volume institutions specialising in beyond TME surgery for locally advanced and recurrent pelvic malignancies between 1990 and 2015. The primary outcome measures were 1-year and 5-year OS. A total of 646 consecutive extended radical resections were performed between 1990 and 2015. The majority were female patients (371, 57.4%) and the median age was 63 years (range 19-89 years). One-year OS, primary rectal adenocarcinoma had the best survival while recurrent colon cancer had the worse survival (p = 0.047). The 5-year OS between primary and recurrent cancers were 64.7% and 53%, respectively (p = 0.004). Poor independent prognostic markers for 5-year OS were increasing ASA score, cardiovascular disease, recurrent cancers, ovarian cancers, pulmonary embolus and acute respiratory distress syndr...Continue Reading

References

Jun 28, 2005·Critical Reviews in Oncology/hematology·Maryska L G Janssen-HeijnenJan Willem W Coebergh
Sep 15, 2006·The New England Journal of Medicine·Jean-François BossetUNKNOWN EORTC Radiotherapy Group Trial 22921
Apr 5, 2007·Annals of Surgical Oncology·Christopher J GannonMiguel A Rodriguez-Bigas
Apr 2, 1949·British Medical Journal·A L WOOLF, H R THOMSON
Jan 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Iris D Nagtegaal, Phil Quirke
Oct 2, 2008·European Journal of Clinical Investigation·F M E WagenlehnerW Weidner
May 8, 2009·World Journal of Surgery·F T J FerenschildJ H W de Wilt
Dec 8, 2009·American Journal of Respiratory and Critical Care Medicine·Frederikus A KlokMenno V Huisman
Feb 9, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gaetan Des GuetzBernard Uzzan
Dec 24, 2010·Diseases of the Colon and Rectum·Nicholas P WestPhilip Quirke
Jun 19, 2012·World Journal of Surgical Oncology·Maureen P KuhrtEdward W Martin
Oct 6, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Panagiotis A GeorgiouGina Brown
Jan 29, 2013·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·H OrtizUNKNOWN Spanish Rectal Cancer Project
Oct 25, 2013·Current Oncology·A Y TashakkorW Y Cheung
Feb 12, 2014·American Journal of Preventive Medicine·Mary C WhiteS Jane Henley
Jul 12, 2014·Gynecologic Oncology·Shannon N WestinPamela T Soliman
Mar 27, 2015·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·M A S KhanR N Saunders
Apr 1, 2015·ANZ Journal of Surgery·Cherng Huei KongDavid A Watters
Jun 23, 2015·The British Journal of Surgery·R W RadwanUNKNOWN Swansea Pelvic Oncology Group
Mar 5, 2016·The British Journal of Surgery·Y N YouG J Chang
May 4, 2017·JAMA Surgery·Sandra I Berríos-TorresUNKNOWN Healthcare Infection Control Practices Advisory Committee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.